Replies to post #3386 on Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

RXi Pharmaceuticals Fortifies its Novel RNAi Patent Portfolio with Notice of Allowance for Lead Clinical Candidate RXI-109

http://finance.yahoo.com/news/rxi-pharmaceuticals-fortifies-novel-rnai-110200185.html

Anyone catch the message from the Press release today?

"This patent protection for our novel self-delivering RNAi technology further strengthens our position to generate business and commercial development opportunities in the areas of dermal and ocular scarring as well as other fibrotic indications, such as liver fibrosis".

Look at the end the CEO says potential partnerships with other fibrotic indications such as liver fibrosis. Hint Hint hint.....